(Q34203149)

31 July 2017

title

SPINK1 protein expression and prostate cancer progression (English)

1 reference

31 July 2017

1 reference

Richard Flavin

1

0 references

Jennifer R Stark

Jennifer R Rider

15

0 references

Stephen P. Finn

Stephen Finn

5

0 references

Katja Fall

Katja Fall

19

0 references

Philip W. Kantoff

Philip Kantoff

21

0 references

Lorelei A. Mucci

24

Lorelei A Mucci

1 reference

31 July 2017

Edward L. Giovannucci

20

Edward Giovannucci

1 reference

31 July 2017

23

Massimo Loda

1 reference

31 July 2017

22

Meir Stampfer

1 reference

31 July 2017

17

Christopher Sweeney

1 reference

31 July 2017

Whitney K Hendrickson

3

Whitney K Hendrickson

1 reference

31 July 2017

Michelangelo Fiorentino

4

Michelangelo Fiorentino

1 reference

31 July 2017

7

Gregory L Judson

1 reference

31 July 2017

8

Rosina Lis

1 reference

31 July 2017

10

Christopher Fiore

1 reference

31 July 2017

14

Kathryn L Penney

1 reference

31 July 2017

16

Jennifer Sinnott

1 reference

31 July 2017

18

Howard D Sesso

1 reference

31 July 2017

Andreas Pettersson

2

1 reference

31 July 2017

Lauren Kunz

6

1 reference

31 July 2017

Dyane Bailey

9

1 reference

31 July 2017

Elizabeth Nuttall

11

1 reference

31 July 2017

Neil E Martin

12

1 reference

31 July 2017

Edward Stack

13

1 reference

31 July 2017

language of work or name

English

0 references

publication date

31 March 2014

1 reference

31 July 2017

published in

Clinical Cancer Research

1 reference

31 July 2017

volume

20

1 reference

31 July 2017

issue

18

1 reference

31 July 2017

page(s)

4904-4911

1 reference

A high-density tissue microarray from patients with clinically localized prostate cancer reveals ERG and TATI exclusivity in tumor cells.

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167171

Novel dual-color immunohistochemical methods for detecting ERG-PTEN and ERG-SPINK1 status in prostate carcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167171

The TMPRSS2:ERG rearrangement, ERG expression, and prostate cancer outcomes: a cohort study and meta-analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167171

Utility of multispectral imaging in automated quantitative scoring of immunohistochemistry

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167171

ERG status is unrelated to PSA recurrence in radically operated prostate cancer in the absence of antihormonal therapy.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167171

Immunohistochemistry for ERG expression as a surrogate for TMPRSS2-ERG fusion detection in prostatic adenocarcinomas

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167171

PTEN loss in the continuum of common cancers, rare syndromes and mouse models.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167171

Therapeutic targeting of SPINK1-positive prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167171

Antibody-based detection of ERG rearrangement-positive prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167171

PTEN genomic deletion is an early event associated with ERG gene rearrangements in prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167171

Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progression

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167171

Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167171

Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167171

Aberrant cytoplasmic expression of p63 and prostate cancer mortality

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167171

Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167171

The role of SPINK1 in ETS rearrangement-negative prostate cancers

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167171

Tenets of PTEN tumor suppression

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167171

Increased expression of tumor-associated trypsin inhibitor, TATI, in prostate cancer and in androgen-independent 22Rv1 cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167171

A randomized trial of aspirin and beta-carotene among U.S. physicians

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167171

SPINK1 expression is tightly linked to 6q15- and 5q21-deleted ERG-fusion negative prostate cancers but unrelated to PSA recurrence

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167171

Antibody EPR3864 is specific for ERG genomic fusions in prostate cancer: implications for pathological practice.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167171

Integration of ERG gene mapping and gene-expression profiling identifies distinct categories of human prostate cancer

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167171

Interactions and relationships of PTEN, ERG, SPINK1 and AR in castration-resistant prostate cancer

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167171

Association of SPINK1 expression and TMPRSS2:ERG fusion with prognosis in endocrine-treated prostate cancer

9 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24687926

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1158/1078-0432.CCR-13-1341

1 reference

31 July 2017

1 reference

31 July 2017

1 reference